The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 594-601

  Levitsky, Victor ^a   De Campos Lima, Pedro Otavio ^a,b   Frisan, Teresa ^a   Masucci, Maria G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA A ANTIGEN; OKT 8; PEPTIDE; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ARTICLE; CELL SELECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; TARGET CELL; VIRUS INFECTION;

AMINO ACID SEQUENCE; CELL LINE, TRANSFORMED; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0032528501     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Sprent, J. 1997. Immunological memory. Curr. Opin. Immunol. 9:371.
2. Zinkernagel, R. M., M. F. Bachmann, T. Kündig, S. Oehen, H. Pirchet, and H. Hengartner. 1996. On immunological memory. Annu. Rev. Immunol. 14:333.
3. McHeyzer-Williams, M. G. 1996. Visualizing immune responses in vivo. Curr. Opin. Immunol. 8:321.
4. Müllbacher, A., and K. Flynn. 1996. Aspects of cytotoxic T cell memory. Immunol. Rev. 113.
5. + T-cell memory determined by clonal burst size. Nature 369:652.
6. Bruno, L., J. Kirberg, and H. von Boehmer. 1995. On the cellular basis of immunological memory. Immunity 2:37.
7. Lau, L. L., B. D. Jamieson, R. Somasundaram, and R. Ahmed. 1994. Cytotoxic T cell memory without antigen. Nature 1994:648.
8. Müllbacher, A. 1994. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 179:317.
9. Bachmann, M. F., T. M. Kündig, H. Hengartner, and R. Zinkernagel. 1997. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cell: T cell memory without "memory T cells?" Proc. Natl. Acad. Sci. USA 94:640.
10. Evavold, B. D., J. Sloan-Lancaster, K. J. Wilson, J. B. Rothbard, and P. M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
11. Matsushita, S., H. Kohsaka, and Y. Nishimura. 1997. Evidence for self and nonself peptide partial agonists that prolong clonal survival of mature T cells in vitro. J. Immunol. 158:5685.
12. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947.
13. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179: 1933.
14. Beverly, P. C. L. 1990. Is T cell memory maintained by cross-reactive stimulation. Immunol. Today 11:203.
15. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.
16. + memory T cells in virus-infected hosts. J. Exp. Med. 183:1367.
17. Maryanski, J. L., V. C. Jongeneel, P. Bucher, J.-L. Casanova, and P. R. Walker. 1996. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity 4:47.
18. McHeyzer-Williams, M. G., and M. M. Davis. 1995. Antigen-specific development of primary and memory T cells in vitro. Science 268:106.
19. Kalams, S. A., P. R. Johnson, A. K. Trocha, M. J. Dynan, S. H. Ngo, R. T. D'Aquila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261.
20. Wucherpfenning, K. W., J. Zhang, C. Witek, M. Matsui, Y. Modabber, K. Ota, and D. A. Hafler. 1994. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152: 5581.
21. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus. In Fields Virology, Vol. 2. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, pp. 2397-2446.
22. Masucci, M. G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol. 2:125.
23. de Campos-Lima, P. O., V. Levitsky, J. Brooks, S. P. Lee, L. F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutations of anchor residues. J. Exp. Med. 179:1297.
24. Gavioli, R., M. G. Kurilla, P.-O. De Campos-Lima, L. E. Wallace, R. Dolcetti, R. J. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572.
25. de Campos-Lima, P.-O., V. Levitsky, M. Imreh, R. Gavioli, and M. G. Masucci. 1996. Epitope-dependent selection of highly restricted or diverse T-cell repertoires in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 186:83.
26. + population. Science 260:98.
27. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190.
28. Hirs, C., and S. Timasheff. 1977. Methods of peptide synthesis. In Enzyme Structure, Vol. 47. Academic Press, New York, pp. 501-617.
29. Dumas, B. T. 1975. Standards for total serum protein assays: a collaborative study. Clin. Chem. 21:1159.
30. Torsteinsdottir, S., M. G. Masucci, B. Ehlin-Henriksson, C. Brautbar, H. Ben Bassat, G. Klein, and E. Klein. 1986. Differentiation dependent sensitivity of human B-cell derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc. Natl. Acad. Sci. USA 83:5620.
31. Rabin, H., R. F. Hopkins, F. W. Ruscetti, R. H. Neubawer, R. L. Brown, and T. G. Kawakami. 1981. Spontaneous release of a factor with properties of T-cell growth factor from a continuous line of primate tumor T cells. J. Immunol. 127: 1852.
32. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
33. Perosa, F., R. Carbone, S. Ferrone, and F. Dammacco. 1990. Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J. Immunol. Methods 128:9.
34. Levitsky, V., Q.-J. Zhang, J. Levitskaja, and M. G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183: 915.
35. Mclean, A. R., and C. Michie. 1995. In vivo estimates of division and death rates of human T lymphocytes. Proc. Natl. Acad. Sci. USA 92:3707.
36. Chen, F., J.-Z. Zou, L. di Renzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752.
37. Miyashita, E. M., B. Yang, K. M. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cell in vivo. Cell 80:593.
38. Heslop, H. E., C. Y. C. Ng, C. Li, C. A. Smith, S. K. Loftin, R. A. Krance, M. K. Brenner, and C. M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:551.
39. Rooney, C. M., C. A. Smith, C. Y. C. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9.
40. Yao, Q. Y., A. B. Rickinson, and M. A. Epstein. 1985. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer 35:35.
41. Robinson, J., D. Smith, and J. Niederman. 1980. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature 187:234.
42. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
43. Berek, C., and C. Milstein. 1987. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 96:23.
44. Weinand, R. G. 1990. Somatic mutation, affinity maturation and the antibody repertoire: a computer model. J. Theor. Biol. 143:343.
45. Moretta, A., G. Pantaleo, L. Moretta, and J. C. Cerottini. 1983. Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell population. J. Exp. Med. 179:758.
46. MacDonal, H. R., A. L. Glasebrook, C. Bron, A. Kelso, and J.-C. Cerottini. 1982. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol. Rev. 68:89.
47. Al-Ramadi, B. K., M. T. Jelonek, L. F. Boyd, D. H. Margulies, and A. L. M. Bothwell. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:662.
48. d-restricted cytotoxic T lymphocytes. J. Exp. Med. 173:849.
49. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, Y. E. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387:630.
50. Garcia, C. K., C. A. Scott, A. Brunmark, F. R. Carbone, P. A. Peterson, I. A. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384:577.
51. Silins, S. L., S. M. Cross, S. L. Elliott, S. J. Pye, S. R. Burrows, J. M. Burrows, D. J. Moss, V. P. Argaet, and I. S. Misko. 1996. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J. Exp. Med. 184:1815.
52. Tanchot, C., F. A. Lemonnier, B. Pérarnau, A. A. Freitas, and B. Rocha. 1997. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276:2057.
53. Kirberg, J., A. Berns, and H. von Boehmer. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 1997:1269.
54. Brocker, T. 1997. Survival of mature CD4 T lymphocytes on major histocompatibility complex class II-expressing dentritic cells. J. Exp. Med. 186:1223.
55. Selin, L. K., K. Vergilis, R. M. Welsh, and S. R. Nahill. 1996. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183:2489.
56. Chothia, C., R. D. Boswell, and A. M. Lesk. 1988. The outline structure of the T-cell αβ receptor. EMBO J. 7:3745.
57. Arden, B., S. P. Clark, D. Kabelitz, and T. W. Mak. 1995. Human T-cell receptor variable gene segment families. Immunogenetics 42:455.